The Efficacy of Cognitive Behavioral Therapy in Reducing Fatigue in Patients with Multiple Sclerosis: A Systematic Review and Meta-analysis
Ahmad Hamza1, Ahmad Harb2, Asmaa Nasr3, Nada Mosad4, Sadeel Banikhaled5, Ramadan Abohendia2, Amal Jubran6
1University of Pittsburgh, 2University Of Al-azhar for Boys, 3Qena faculty of medicine south valley university, 4University Of Al-azhar for Girls Demitta, 5University of Jordon, 6Faculty of medicine Al-Balqa Applied University
Objective:
 Multiple sclerosis (MS) patients may benefit from Cognitive Behavioral Therapy (CBT) programs to decrease fatigue and improve their quality of life. Therefore, we aim to systematically review their evidence. 
Background:

Fatigue is one of the most common debilitating symptoms of MS, affecting up to 80% of patients and significantly disrupting their daily lives. However, the underlying mechanism remains unknown. CBT is a well-known therapy for Psychological symptoms of MS. Many programs have been developed to manage fatigue, CBT is an Essential component.


Design/Methods:

We searched online databases such as PubMed, Cochrane Library, Scopus, and Web of Science until September 2024 for studies that matched the eligibility criteria, any clinical trials that utilized CBT programs as an intervention, and any fatigue scales as an outcome focusing on participants aged 18 years or older. We excluded all trials involving pharmacological therapy, case reports, or reviews. We assessed the risk of bias using ROB-2 for RCTs and ROBINS-I for nRCTs. The primary outcomes were the Modified Fatigue Impact Scale (MFIS), Chalder Fatigue Scale (CIS), and Fatigue Severity Scale (FSS). Secondary outcomes included the MS Quality of Life (MSQOL) and Short Form Health Survey (SF-36). Outcomes were qualitatively reviewed, and a meta-analysis was performed using standardized mean difference (SMD) with 95% confidence intervals (CIs) calculated using Review Manager (RevMan).

Results:

Seven RCTs matched the inclusion criteria. Four of these (324 participants) were eligible for the analysis. The overall effect estimate showed that CBT was significantly superior to the standard therapy in terms of fatigue scales (SMD = -0.4, 95% CI [-0.62 -0.18], P = 0.0004). and quality of life (SMD = 0.26, 95% CI [0.00, 0.51], P = 0.05). 

Conclusions:

CBT programs can effectively reduce MS-associated fatigue and maintain their effects for at least 12 months. Nonetheless, they can improve the quality of life compared to standard therapy.

10.1212/WNL.0000000000210860
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.